Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
PPOs may cover GLP-1 medications, but you might face higher copays or coinsurance
Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering
Premiums vary by plan but the average basic monthly premium for a Part D plan in 2023 is $31.50, down from $32.08 in 2022
It is important to note that tirzepatide should not be used concurrently with other GLP-1 receptor agonists
Many women use it as a phase within a broader health plan
Side Effects and Safety Concerns Common Side Effects Nausea Vomiting Fatigue Diarrhea or constipation Acid reflux These typically fade within the first 46 weeks as your body adjusts
US$ 23.80
US$ 25.37
US$ 23.72
